No Data
Haleon PLC: Bergin Is Currently CFO of J Sainsbury
Haleon PLC: Bergin Will Join the Board on Feb. 24
Haleon PLC Appoints Blathnaid Bergin as an Independent Non-Executive Director
Haleon PLC: Decision Follows Reduction of Pfizer's Shareholding in Haleon Below 20%
Haleon PLC: Denton Is a Non-Executive Director, Representative of Pfizer
Pfizer (PFE.US) has applied for clinical trials of its innovative cancer drug in China for the first time, targeting KRAS mutation tumors.
On December 5, the official website of the China National Medical Products Administration's Center for Drug Evaluation (CDE) announced that Pfizer's (PFE.US) class 1 new drug PF-07934040 tablet clinical trial application has been accepted.
蛇蛇 : Next January, take Route 35.
Amusement World : Was demolished lol
J L 7 2 : He will definitely lose money today